The Aptuit Center for Drug Discovery & Development in Verona, Italy has reached its 100th client, according to Stuart Needleman, president and chief operating officer of Aptuit LLC. The Verona facility, which Aptuit bought from GSK in mid-2010, provides drug discovery and development services to large, multinational pharmaceutical companies, mid-sized and small pharma companies, biotechs and startups.   Mark Hembarsky, vice president and site leader of the facility, said, “We are excit...